A 2011 Canadian study identifying traces of an agrichemical-associated protein in pregnant women and fetal cord blood has resurfaced in ongoing discussions about food safety and regulatory response.
By yourNEWS Media Newsroom
A study published in 2011 examining the presence of agrichemical-related compounds in pregnant women and their unborn children is drawing renewed attention, with questions raised about how regulators and researchers responded to its findings.
The research, conducted by scientists at the Université de Sherbrooke Hospital in Montréal, analyzed maternal and fetal blood samples for exposure to compounds associated with genetically modified agriculture. The study, titled “Maternal and fetal exposure to pesticides associated with genetically modified foods”, reported detecting the Cry1Ab protein—an insecticidal toxin derived from Bacillus thuringiensis—in a majority of samples.
According to the findings, 93% of maternal blood samples contained Cry1Ab, while 80% of fetal cord blood samples also tested positive. The results indicated that the protein, commonly associated with genetically modified corn, was present beyond the digestive system and detectable in circulation.
The study has been cited in a report by The Defender, which argued the findings warranted further investigation into potential implications for human health.
Researchers also tested for additional agrichemicals, including glyphosate and glufosinate, herbicides commonly used in conjunction with genetically modified crops. Those compounds were largely not detected in the samples, while Cry1Ab was identified more consistently.
Cry1Ab originates from Bacillus thuringiensis, a soil bacterium historically used in agriculture for pest control. In modern applications, genetic engineering has enabled certain crops to produce the protein internally as a defense against insects.
The study’s findings raised questions about how such proteins interact with the human body, particularly regarding digestion and absorption. Detection in fetal cord blood suggested the protein had crossed the placental barrier, a biological structure that typically limits the transfer of substances between mother and fetus.
In toxicological research, the presence of compounds in fetal circulation can prompt further evaluation of developmental and long-term health effects. However, the study’s conclusions were met with skepticism by some regulatory authorities, who questioned the significance of the detected concentrations.
Regulatory responses in Canada and the United States cited the low levels identified and referenced existing models suggesting that such proteins are expected to break down during digestion. No large-scale follow-up studies or long-term monitoring efforts tied directly to the findings were initiated.
The study has since been referenced in broader discussions about genetically modified crops, which now make up a significant portion of agricultural production in North America. According to reporting on GMO corn production, these crops are widely used in food products, animal feed and industrial applications.
Additional commentary has pointed to the absence of long-term human studies examining prenatal exposure to compounds associated with genetically engineered foods. Articles discussing the safety of genetically modified organisms have highlighted gaps in research frameworks, including the lack of generational or epigenetic studies, as noted in discussions about GMO safety standards.
Comparisons have also been made to other substances known to cross the placenta, such as medications examined in studies like those referenced in reporting on prenatal exposure to Tylenol, where follow-up research has been more extensive.
The broader issue highlighted by the study centers on how emerging scientific findings are evaluated and prioritized for further investigation. Public health discussions continue to emphasize the importance of replication, long-term data collection and transparent review when assessing potential risks associated with widely consumed products.
The findings remain part of an ongoing debate within scientific and regulatory communities regarding agricultural biotechnology, food safety and the need for continued research into human exposure pathways.
Original article
Comments